AKT1 and lung cancer: Our results are in line with those of previous studies, suggesting that gallic acid exhibits anticancer activity by inhibiting the PI3K/Akt pathway in different cancer cell types, including lung cancer, bladder cancer, and myeloid leukemia [19,20,36].